Mereo BioPharma (MREO) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.30 --0%
Financial Fact:
Other general and administrative expenses: 74.75K
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Other general and administrative expenses: 74.75K
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.02).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MercadoLibre shares fall on earnings miss, margin pressure
- Increasing unusual put option volume: DLR EWT XLV FVRR ALL GH NCLD NB APPX BUG NTAP EWJ SEI ONTO EWG ASX DAVE QUBT
- SanDisk shares drop amid chip sector selloff
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
